Condition: Autoimmune Pancreatitis · IgG4-Related Diseases · Pancreatic Cancer · Sponsor: Military Medical Clinical Center of the Southern Region, Ukraine
This ambispective observational study aims to validate the Odesa Criteria 2026 (OC26), a flexible domain-based point scoring system for diagnosing autoimmune pancreatitis. The study evaluates diagnostic accuracy and reproducibility of OC26 across clinical, serological, morphological, and histological domains.
This description comes directly from the study's public registry record.
Oleg Dovbenko, MD, PhD · +380682539685 · dovbenko2015@hotmail.com
Oleg Dovbenko, MD, PhD · +380682539685 · dovbenko73@gmail.com
Always discuss trial participation with your own doctor first.
| Military Medical Clinical Center of the Southern Region | Odesa, Ukraine | Recruiting |
| Military Medical Clinical Center of the Southern Region | Odesa, Ukraine | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07536841